KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock Price (Quote)

$3.36
+0.195 (+6.16%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $3.02 $6.17 Friday, 27th May 2022 CATB stock ended at $3.36. This is 6.16% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 6.65% from a day low at $3.16 to a day high of $3.37.
90 days $3.02 $7.25
52 weeks $1.20 $10.26

Historical Catabasis Pharmaceuticals prices

Date Open High Low Close Volume
Jul 15, 2019 $7.56 $7.75 $7.31 $7.45 48 180
Jul 12, 2019 $7.60 $7.68 $7.41 $7.49 39 009
Jul 11, 2019 $7.66 $7.81 $7.42 $7.60 47 252
Jul 10, 2019 $7.79 $7.79 $7.52 $7.70 55 649
Jul 09, 2019 $7.45 $7.66 $7.30 $7.58 83 100
Jul 08, 2019 $7.47 $7.70 $7.35 $7.44 71 319
Jul 05, 2019 $7.53 $7.70 $7.45 $7.46 45 202
Jul 03, 2019 $7.56 $7.87 $7.50 $7.50 41 700
Jul 02, 2019 $7.65 $7.65 $7.35 $7.54 52 598
Jul 01, 2019 $8.19 $8.19 $7.61 $7.68 57 423
Jun 28, 2019 $7.89 $8.11 $7.63 $8.07 113 344
Jun 27, 2019 $7.91 $8.15 $7.63 $7.80 134 336
Jun 26, 2019 $7.58 $7.77 $7.40 $7.61 52 423
Jun 25, 2019 $7.76 $7.80 $7.33 $7.48 78 381
Jun 24, 2019 $8.10 $8.14 $7.51 $7.71 144 373
Jun 21, 2019 $7.70 $7.88 $7.30 $7.59 159 908
Jun 20, 2019 $7.30 $7.68 $7.20 $7.49 191 457
Jun 19, 2019 $6.49 $6.93 $6.40 $6.84 74 982
Jun 18, 2019 $6.27 $6.49 $6.17 $6.45 61 702
Jun 17, 2019 $5.87 $6.19 $5.85 $6.05 31 832
Jun 14, 2019 $5.95 $6.13 $5.83 $5.89 41 604
Jun 13, 2019 $6.00 $6.02 $5.89 $5.95 54 465
Jun 12, 2019 $5.98 $6.17 $5.67 $5.90 46 024
Jun 11, 2019 $6.00 $6.00 $5.67 $5.86 77 524
Jun 10, 2019 $6.14 $6.17 $5.86 $5.95 100 235
Click to get the best stock tips daily for free!

About Catabasis Pharmaceuticals

Catabasis Pharmaceuticals Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i... CATB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT